Early and Complete Response of Bone Metastases, Documented by FDG-PET/CT Scan, in a Patient With NSCLC

David Rossi; Paolo Giordani; Paolo Alessandroni; Vincenzo Catalano; Virginia Casadei; Anna Maria Baldelli; Stefano Luzi Fedeli; Francesco Graziano; Giammaria Fiorentini

doi:10.4021/wjon441w

Early and Complete Response of Bone Metastases, Documented by FDG-PET/CT Scan, in a Patient With NSCLC

World J Oncol. 2012 Feb;3(1):39-41. doi: 10.4021/wjon441w. Epub 2012 Feb 19.

Authors

David Rossi¹, Paolo Giordani¹, Paolo Alessandroni¹, Vincenzo Catalano¹, Virginia Casadei¹, Anna Maria Baldelli¹, Stefano Luzi Fedeli¹, Francesco Graziano¹, Giammaria Fiorentini¹

Affiliation

¹ Azienda Ospedaliera "Ospedali Riuniti Marche Nord", Presidio "San Salvatore" di Pesaro, Italy.

Abstract

In this case report we describe the case of a patient with multiple bone metastases of NSCLC, adenocarcinoma with exon 21 point-mutation of EGFR, treated with gefitinib. After only 3 months, FDG-PET/CT scan showed a complete response of bone metastases and right hylar adenopathy. Implications for need of early use of FDG-PET/CT scan after gefitinib treatment are discussed.

Keywords: Gefitinib; NSCLC; PET/CT scan.

Publication types

Case Reports